Burridge PW, Matsa E, Ebert AD, Wu H, Fuga Y, Wilson KD, Churko JM, Mordwinkin NN, Ong S-G, Chang AC, Metzler SA, Simmons CS, Knowles JW, Telli ML, Witteles RM, Blau HM, Altman RB, Bernstein D, Gold JD, Wu JC. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to Doxorubicin-Induced Cardiotoxicity. Nature Medicine 22:547-56, 2016. PMID: 27089514.